| P2093 | author name string | James T Thackeray | |
| | Jean N Dasilva | |
| | Rob S Beanlands | |
| P2860 | cites work | Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography | Q48435829 |
| | Impairment of sympathetic baroreceptor reflexes in obese Zucker rats | Q48572706 |
| | Biodistribution and metabolism of [N-methyl-11C]m-hydroxyephedrine in the rat. | Q48663726 |
| | Effects of streptozotocin diabetes on the noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study | Q48940206 |
| | Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. | Q51574264 |
| | Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. | Q51624475 |
| | Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats. | Q53208627 |
| | Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET. | Q53236764 |
| | The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation | Q31952520 |
| | Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes | Q34024314 |
| | Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography | Q34188430 |
| | Assessment of cardiac sympathetic nerve integrity with positron emission tomography | Q34343189 |
| | Adaptation and maladaptation of the heart in diabetes: Part I: general concepts | Q34592521 |
| | Cardiac adrenoceptors: physiological and pathophysiological relevance | Q34652037 |
| | Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia. | Q35206048 |
| | Myocardial performance in conscious streptozotocin diabetic rats | Q35221216 |
| | Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography | Q35371001 |
| | Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes | Q35404816 |
| | Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy | Q35765497 |
| | Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy | Q35791559 |
| | Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders | Q36074583 |
| | Mechanisms of insulin resistance in humans and possible links with inflammation | Q36095510 |
| | Cardiac sympathetic neuronal imaging using PET. | Q36811189 |
| | Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75. | Q37093823 |
| | Interaction of diet and diabetes on cardiovascular function in rats | Q37100156 |
| | Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance | Q37105295 |
| | New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: the regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance | Q37409130 |
| | (-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists | Q37677322 |
| | The role of cardiac PET in translating basic science into the clinical arena | Q37875793 |
| | Risk stratification in heart failure using ¹²³I-MIBG. | Q37942114 |
| | PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram. | Q37970735 |
| | Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. | Q38322188 |
| | Myocardial sympathetic innervation in patients with symptomatic coronary artery disease: follow-up after 1 year with neurostimulation | Q39315786 |
| | Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A a | Q40000258 |
| | Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study | Q40045018 |
| | Sympathoadrenal system and regulation of thermogenesis | Q40183781 |
| | Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. | Q40471264 |
| | Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation | Q40639602 |
| | Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy | Q40855375 |
| | Changes in myocardial and vascular receptors in heart failure | Q40858004 |
| | Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies | Q41128067 |
| | The beta-adrenergic radioligand [3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue | Q41876320 |
| | Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy | Q42223835 |
| | Heart rate variability and baroreceptor function in chronic diabetic rats | Q42445153 |
| | Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury. | Q42812966 |
| | Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide | Q42820917 |
| | Molecular Imaging of Cardiac Sympathetic Innervation by 11C-mHED and PET: From Man to Mouse? | Q42948997 |
| | Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients | Q43032063 |
| | PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart. | Q53247950 |
| | Presence of specific 11C-meta-Hydroxyephedrine retention in heart, lung, pancreas, and brown adipose tissue. | Q53463767 |
| | Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. | Q53657667 |
| | Formation of alpha-methylnorepinephrine as a metabolite of metaraminol in guinea pigs. | Q53944244 |
| | Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. | Q54017801 |
| | Reflex sympathetic activation induces acute insulin resistance in the human forearm. | Q54240946 |
| | Myocardial Presynaptic and Postsynaptic Autonomic Dysfunction in Hypertrophic Cardiomyopathy | Q59845538 |
| | Regional pre- and postsynaptic sympathetic system in the failing human heart - regulation of βARK-1 | Q60607093 |
| | Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography | Q60607105 |
| | Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans | Q60607134 |
| | A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry | Q64112301 |
| | Norepinephrine storage, distribution, and release in diabetic cardiomyopathy | Q68159398 |
| | Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging | Q68884398 |
| | Plasma membrane-specific deficiency in cardiac beta-adrenergic receptor in streptozocin-diabetic rats | Q69372923 |
| | Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy | Q69484216 |
| | Correlation of cardiovascular and neuroendocrine tests of autonomic function in diabetes | Q70034782 |
| | The adrenergic beta-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin-diabetic rats. In vivo and in vitro evidence for a desensitized myocardial beta-receptor | Q70180123 |
| | Reversibility of diabetic cardiomyopathy with insulin in rats | Q70195592 |
| | Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure | Q70376386 |
| | Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies | Q70657272 |
| | Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension | Q71387665 |
| | Synthesis and preliminary evaluation of [11C]-(-)-phenylephrine as a functional heart neuronal PET agent | Q71753634 |
| | Myocardial and pulmonary uptake of S-1'-[18F]fluorocarazolol in intact rats reflects radioligand binding to beta-adrenoceptors | Q72147858 |
| | Baroreflex function in streptozotocin (STZ) induced diabetic rats | Q72313713 |
| | Cardiac autonomic receptors: effect of long-term experimental diabetes | Q72386472 |
| | Alloxan-Induced Diabetes Reduces β-Adrenergic Receptor Number Without Affecting Adenylate Cyclase in Rat Ventricular Membranes | Q72702455 |
| | Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine | Q72817956 |
| | Norepinephrine reuptake, baroreflex dynamics, and arterial pressure variability in rats | Q72997962 |
| | Beta-andrenoceptors in the hearts of diabetic-hypertensive rats: radioligand binding and functional experiments | Q73263076 |
| | Myocardial kinetics of carbon-11-epinephrine in the isolated working rat heart | Q73384794 |
| | Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation | Q73511291 |
| | The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts | Q73679995 |
| | Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes | Q74607826 |
| | Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine | Q77107710 |
| | Effects of glucose intolerance on myocardial function and collagen-linked glycation | Q77948229 |
| | Diabetes-induced down-regulation of beta1-adrenoceptor mRNA expression in rat heart | Q78130870 |
| | Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic control | Q78244909 |
| | Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis | Q79917829 |
| | Pre- and post-synaptic sympathetic function in human hibernating myocardium | Q80695335 |
| | Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction | Q81303349 |
| | Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction | Q82381386 |
| | Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus | Q82766354 |
| | Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients | Q83070863 |
| | Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat | Q83166687 |
| | Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study | Q43147933 |
| | Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity. | Q43150579 |
| | Sympathetic and haemodynamic responses to lipids in healthy human ageing | Q43198522 |
| | Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats | Q43251443 |
| | 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study | Q43266229 |
| | Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes. | Q43293514 |
| | The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptor subtypes in the rat. | Q43651054 |
| | Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients | Q43672383 |
| | beta-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat. | Q43682800 |
| | Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes | Q43706321 |
| | Regulation of cardiac transient outward potassium current by norepinephrine in normal and diabetic rats | Q43729351 |
| | Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy | Q43819739 |
| | Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms | Q43961175 |
| | Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats | Q44098337 |
| | Neuronal mapping of the heart with 6-[18F]fluorometaraminol | Q44127932 |
| | Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging | Q44138116 |
| | Cardiovascular autonomic function in conscious rats: a novel approach to facilitate stationary conditions | Q44216065 |
| | A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes | Q44353731 |
| | Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. | Q44403571 |
| | Diabetes-induced biochemical changes in central and peripheral catecholaminergic systems. | Q44670524 |
| | A conceptual paradox of MIBG uptake in heart failure: retention with incontinence! | Q44688562 |
| | PET measures of pre- and post-synaptic cardiac beta adrenergic function | Q44708773 |
| | Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies | Q45010779 |
| | Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction | Q45192969 |
| | beta-Adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes. | Q45202748 |
| | Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. | Q45216941 |
| | Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. | Q45286425 |
| | Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. | Q45812025 |
| | Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats | Q46084031 |
| | Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate | Q46096897 |
| | Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart | Q46114384 |
| | Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy | Q46151020 |
| | Mechanisms of alpha1-adrenoceptor mediated QT prolongation in the diabetic rat heart | Q46169689 |
| | Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction | Q46231208 |
| | Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration. | Q46365517 |
| | Myocardial 11C-diacylglycerol accumulation and left ventricular remodeling in patients after myocardial infarction. | Q46421491 |
| | Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3. | Q46429756 |
| | In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat. | Q46541602 |
| | Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction | Q46556133 |
| | Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. | Q46639259 |
| | Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. | Q46642906 |
| | Functional changes in baroreceptor afferent, central and efferent components of the baroreflex circuitry in type 1 diabetic mice (OVE26). | Q46712111 |
| | Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. | Q46802160 |
| | Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure | Q46805027 |
| | Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice | Q46827454 |
| | Long-term effects of type 2 diabetes mellitus on heart rhythm in the Goto-Kakizaki rat. | Q46835326 |
| | Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats | Q46906795 |
| | Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy | Q46945336 |
| | In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. | Q48316017 |
| | Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats | Q48378474 |
| P433 | issue | 3 | |
| P304 | page(s) | 314-334 | |
| P577 | publication date | 2012-07-20 | |
| P1433 | published in | American journal of nuclear medicine and molecular imaging | Q27723780 |
| P1476 | title | Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging | |
| P478 | volume | 2 | |